CIK 0001935979 · Large accelerated filer
Biohaven Ltd.
Sign in to watch- Ticker
- BHVN
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Virgin Islands, British
- Entity type
- operating
- Phone
- 203-404-0410
- Business address
- 215 CHURCH STREET, NEW HAVEN, CT, 06510
- Former names
- Biohaven Research Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-10-03 | Gentile Kimberly SVP, Clinical Operations | Other acquisition · Stock Options (Right to Buy) | +30,958 | 30,958 | ||
| 2022-10-03 | Gentile Kimberly SVP, Clinical Operations | Other acquisition · Stock Options (Right to Buy) | +1,542 | 1,542 | ||
| 2022-10-03 | Gentile Kimberly SVP, Clinical Operations | Other acquisition · Stock Options (Right to Buy) | +295 | 295 | ||
| 2022-10-03 | Gentile Kimberly SVP, Clinical Operations | Other acquisition · Stock Options (Right to Buy) | +20,716 | 20,716 | ||
| 2022-10-03 | Gentile Kimberly SVP, Clinical Operations | Other acquisition · Stock Options (Right to Buy) | +4,500 | 4,500 | ||
| 2022-10-03 | Gentile Kimberly SVP, Clinical Operations | Other acquisition · Stock Options (Right to Buy) | +12,500 | 12,500 | ||
| 2022-10-03 | Gentile Kimberly SVP, Clinical Operations | Option exercise · Stock Options (Right to Buy) | −387 | 0 | ||
| 2022-10-03 | Gentile Kimberly SVP, Clinical Operations | Option exercise · Stock Options (Right to Buy) | −12,612 | 0 | ||
| 2022-10-03 | Gentile Kimberly SVP, Clinical Operations | Option exercise · Stock Options (Right to Buy) | −1,199 | 0 | ||
| 2022-10-03 | Gentile Kimberly SVP, Clinical Operations | Option exercise · Stock Options (Right to Buy) | −13,801 | 0 | ||
| 2022-10-03 | Gentile Kimberly SVP, Clinical Operations | Option exercise · Stock Options (Right to Buy) | −14,000 | 0 | ||
| 2022-10-03 | Gentile Kimberly SVP, Clinical Operations | Option exercise · Stock Options (Right to Buy) | −3,000 | 0 | ||
| 2022-10-03 | Gentile Kimberly SVP, Clinical Operations | Option exercise · Stock Options (Right to Buy) | −30,958 | 0 | ||
| 2022-10-03 | Gentile Kimberly SVP, Clinical Operations | Option exercise · Stock Options (Right to Buy) | −1,542 | 0 | ||
| 2022-10-03 | Gentile Kimberly SVP, Clinical Operations | Option exercise · Stock Options (Right to Buy) | −295 | 0 | ||
| 2022-10-03 | Gentile Kimberly SVP, Clinical Operations | Option exercise · Stock Options (Right to Buy) | −20,716 | 0 | ||
| 2022-10-03 | Gentile Kimberly SVP, Clinical Operations | Option exercise · Stock Options (Right to buy) | −4,500 | 0 | ||
| 2022-10-03 | Gentile Kimberly SVP, Clinical Operations | Option exercise · Stock Option (Right to Buy) | −12,500 | 0 | ||
| 2022-10-03 | Gentile Kimberly SVP, Clinical Operations | Grant or award · Stock Options (Right to buy) | +300,000 | 300,000 | ||
| 2022-10-03 | Antonijevic Irina Director | Other acquisition | +2,535 | 2,535 |
Page 11 of 18 · 355 trades